Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban versus standard anticoagulation in pediatric cardiac disease at risk of thromboembolism
2017-000475-90Phase 3Unknown
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in thromboembolism comparing Edoxaban with Standard of care anticoagulation (2 arms). Primary endpoint: Primary safety endpoint. Status: unknown.
02
Drugs
edoxaban
03
Conditions
thromboembolism
Beyond the preview
Go deeper on 2017-000475-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000475-90.